| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.2 | 0.3 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.2 | 0.3 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.16 | 0.2 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.15 | 0.3 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.15 | 9e-05 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0006 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.03 |